{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T14:27:57Z","timestamp":1778336877640,"version":"3.51.4"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,6,8]],"date-time":"2014-06-08T00:00:00Z","timestamp":1402185600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s00280-014-2507-8","type":"journal-article","created":{"date-parts":[[2014,6,10]],"date-time":"2014-06-10T22:48:32Z","timestamp":1402440512000},"page":"283-289","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Influence of genetic polymorphisms of FPGS, GGH, and MTHFR on serum methotrexate levels in Chinese children with acute lymphoblastic leukemia"],"prefix":"10.1007","volume":"74","author":[{"given":"Shu-mei","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu-lu","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-xin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan-shui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo-liang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,6,8]]},"reference":[{"key":"2507_CR1","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1056\/NEJMra052603","volume":"354","author":"CH Pui","year":"2006","unstructured":"Pui CH, Evans WE (2006) Treatment of acute lymphoblastic leukemia. N Engl J Med 354:166\u2013178","journal-title":"N Engl J Med"},{"key":"2507_CR2","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.seminhematol.2008.09.007","volume":"46","author":"M Stanulla","year":"2009","unstructured":"Stanulla M, Schrappe M (2009) Treatment of childhood acute lymphoblastic leukemia. Semin Hematol 46:52\u201363","journal-title":"Semin Hematol"},{"key":"2507_CR3","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2165\/00003088-200039050-00004","volume":"39","author":"HJ Bongard Van Den","year":"2000","unstructured":"Van Den Bongard HJ, Mathot RA, Beijnen JH, Schellens JH (2000) Pharmacokinetically guided administration of chemotherapeutic agents. Clin Pharmacokinet 39:345\u2013367","journal-title":"Clin Pharmacokinet"},{"key":"2507_CR4","first-page":"2053","volume":"29","author":"NM El-Khodary","year":"2012","unstructured":"El-Khodary NM, El-Haggar SM, Eid MA, Ebeid EN (2012) Study of the pharmacokinetic and pharmacogenetic contribution to the toxicity of high-dose methotrexate in children with acute lymphoblastic leukemia 29:2053\u20132062","journal-title":"Study of the pharmacokinetic and pharmacogenetic contribution to the toxicity of high-dose methotrexate in children with acute lymphoblastic leukemia"},{"key":"2507_CR5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1172\/JCI118409","volume":"97","author":"E Masson","year":"1996","unstructured":"Masson E, Relling MV, Synold TW, Liu Q, Schuetz JD, Sandlund JT, Pui CH, Evans WE (1996) Accumulation of methotrexate polyglutamates in lymphoblasts is a determinant of antileukemic effects in vivo. A rationale for high-dose methotrexate. J Clin Invest 97:73\u201380","journal-title":"J Clin Invest"},{"key":"2507_CR6","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0163-7258(85)90083-X","volume":"28","author":"ID Goldman","year":"1985","unstructured":"Goldman ID, Matherly LH (1985) The cellular pharmacology of methotrexate. Pharmacol Ther 28:77\u2013102","journal-title":"Pharmacol Ther"},{"key":"2507_CR7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0006-291X(73)90949-2","volume":"52","author":"CM Baugh","year":"1973","unstructured":"Baugh CM, Krumdieck CL, Nair MG (1973) Polygammaglutamyl metabolites of methotrexate. Biochem Biophys Res Commun 52:27\u201334","journal-title":"Biochem Biophys Res Commun"},{"key":"2507_CR8","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1080\/10428190701824569","volume":"49","author":"AK Fotoohi","year":"2008","unstructured":"Fotoohi AK, Albertioni F (2008) Mechanisms of antifolate resistance and methotrexate efficacy in leukemia cells. Leuk Lymphoma 49:410\u2013426","journal-title":"Leuk Lymphoma"},{"key":"2507_CR9","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1056\/NEJM199610033351408","volume":"335","author":"R Gorlick","year":"1996","unstructured":"Gorlick R, Goker E, Trippett T, Waltham M, Banerjee D, Bertino JR (1996) Intrinsic and acquired resistance to methotrexate in acute leukemia. N Engl J Med 335:1041\u20131048","journal-title":"N Engl J Med"},{"key":"2507_CR10","first-page":"150","volume":"21","author":"H Schr\u00f8der","year":"1988","unstructured":"Schr\u00f8der H, Fogh K, Herlin T (1988) In vivo decline of methotrexate and methotrexate polyglutamates in age-fractionated erythrocytes. Cancer Chemother Pharmacol 21:150\u2013155","journal-title":"Cancer Chemother Pharmacol"},{"key":"2507_CR11","doi-asserted-by":"crossref","first-page":"e1001019","DOI":"10.1371\/journal.pcbi.1001019","volume":"6","author":"JC Panetta","year":"2010","unstructured":"Panetta JC, Sparreboom A, Pui CH, Relling MV, Evans WE (2010) Modeling mechanisms of in vivo variability in methotrexate accumulation and folate pathway inhibition in acute lymphoblastic leukemia cells. PLoS Comput Biol 6:e1001019","journal-title":"PLoS Comput Biol"},{"key":"2507_CR12","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0378-1119(03)00807-2","volume":"319","author":"KJ Chave","year":"2003","unstructured":"Chave KJ, Ryan TJ, Chmura SE, Galivan J (2003) Identification of single nucleotide polymorphisms in the human gamma-glutamyl hydrolase gene and characterization of promoter polymorphisms. Gene 319:167\u2013175","journal-title":"Gene"},{"key":"2507_CR13","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2217\/14622416.8.2.141","volume":"8","author":"RJ Straaten van der","year":"2007","unstructured":"van der Straaten RJ, Wessels JA, De Vries-Bouwstra JK, Goekoop-Ruiterman YP, Allaart CF, Bogaartz J, Tiller M, Huizinga TW, Guchelaar HJ (2007) Exploratory analysis of four polymorphisms in human GGH and FPGS genes and their effect in methotrexate-treated rheumatoid arthritis patients. Pharmacogenomics 8:141\u2013150","journal-title":"Pharmacogenomics"},{"key":"2507_CR14","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1097\/FPC.0b013e328311a8fd","volume":"18","author":"S Sharma","year":"2008","unstructured":"Sharma S, Das M, Kumar A, Marwaha V, Shankar S, Aneja R, Grover R, Arya V, Dhir V, Gupta R, Kumar U, Juyal RC, Thelma BK (2008) Interaction of genes from influx-metabolism-efflux pathway and their influence on methotrexate efficacy in rheumatoid arthritis patients among Indians. Pharmacogenet Genomics 18:1041\u20131049","journal-title":"Pharmacogenet Genomics"},{"key":"2507_CR15","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1097\/FPC.0b013e328331b53e","volume":"19","author":"S Sharma","year":"2009","unstructured":"Sharma S, Das M, Kumar A, Marwaha V, Shankar S, Singh P, Raghu P, Aneja R, Grover R, Arya V, Dhir V, Gupta R, Kumar U, Juyal RC, BK T (2009) Purine biosynthetic pathway genes and methotrexate response in rheumatoid arthritis patients among north Indians. Pharmacogenet Genomics 19:823\u2013828","journal-title":"Pharmacogenet Genomics"},{"key":"2507_CR16","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1093\/annonc\/mdf322","volume":"13","author":"P Chiusolo","year":"2002","unstructured":"Chiusolo P, Reddiconto G, Casorelli I, Laurenti L, Sora F, Mele L, Annino L, Leone G, Sica S (2002) Preponderance of methylenetetrahydrofolate reductase c677t homozygosity among leukemia patients intolerant to methotrexate. Ann Oncol 13:1915\u20131918","journal-title":"Ann Oncol"},{"key":"2507_CR17","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/00008571-200204000-00002","volume":"12","author":"W Urano","year":"2002","unstructured":"Urano W, Taniguchi A, Yamanaka H, Tanaka E, Nakajima H, Matsuda Y, Akama H, Kitamura Y, Kamatani N (2002) Polymorphisms in the methylenetetrahydrofolate reductase gene were associated with both the efficacy and the toxicity of methotrexate used for the treatment of rheumatoid arthritis, as evidenced by single locus and haplotype analyses. Pharmacogenetics 12:183\u2013190","journal-title":"Pharmacogenetics"},{"key":"2507_CR18","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/ijc.10847","volume":"103","author":"G Toffoli","year":"2003","unstructured":"Toffoli G, Russo A, Innocenti F, Corona G, Tumolo S, Sartor F, Mini E, Boiocchi M (2003) Effect of methylenetetrahydrofolate reductase 677C\u2013>T polymorphism on toxicity and homocysteine plasma level after chronic methotrexate treatment of ovarian cancer patients. Int J Cancer 103:294\u2013299","journal-title":"Int J Cancer"},{"key":"2507_CR19","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1517\/14622416.5.5.559","volume":"5","author":"P Ranganathan","year":"2004","unstructured":"Ranganathan P, Culverhouse R, Marsh S, Ahluwalia R, Shannon WD, Eisen S, McLeod HL (2004) Single nucleotide polymorphism profiling across the methotrexate pathway in normal subjects and patients with rheumatoid arthritis. Pharmacogenomics 5:559\u2013569","journal-title":"Pharmacogenomics"},{"key":"2507_CR20","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.7314\/APJCP.2012.13.7.3461","volume":"13","author":"N Koomdee","year":"2012","unstructured":"Koomdee N, Hongeng S, Apibal S, Pakakasama S (2012) Association between polymorphisms of dihydrofolate reductase and gamma glutamyl hydrolase genes and toxicity of high dose methotrexate in children with acute lymphoblastic leukemia. Asian Pac J Cancer Prev 13:3461\u20133464","journal-title":"Asian Pac J Cancer Prev"},{"issue":"13","key":"2507_CR21","first-page":"107","volume":"29","author":"SG Liu","year":"2013","unstructured":"Liu SG, Gao C, Zhang RD, Jiao Y, Cui L, Li WJ, Chen ZP, Wu MY, Zheng HY, Zhao XX, Yue ZX, Li ZG (2013) FPGS rs1544105 polymorphism is associated with treatment outcome in pediatric B-cell precursor acute lymphoblastic leukemia. Cancer Cell Int 29(13):107","journal-title":"Cancer Cell Int"},{"key":"2507_CR22","doi-asserted-by":"crossref","first-page":"12810","DOI":"10.1073\/pnas.96.22.12810","volume":"96","author":"CF Skibola","year":"1999","unstructured":"Skibola CF, Smith MT, Kane E, Roman E, Rollinson S, Cartwright RA, Morgan G (1999) Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc Natl Acad Sci USA 96:12810\u201312815","journal-title":"Proc Natl Acad Sci USA"},{"key":"2507_CR23","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1158\/1055-9965.1436.13.9","volume":"13","author":"S Narayanan","year":"2004","unstructured":"Narayanan S, McConnell J, Little J, Sharp L, Piyathilake CJ, Powers H, Basten G, Duthie SJ (2004) Associations between two common variants c677t and a1298c in the methylenetetrahydrofolate reductase gene and measures of folate metabolism and DNA stability (strand breaks, misincorporated uracil, and DNA methylation status) in human lymphocytes in vivo. Cancer Epidemiol Biomarkers Prev 13:1436\u20131443","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"2507_CR24","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/ng0595-111","volume":"10","author":"P Frosst","year":"1995","unstructured":"Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, Boers GJ, den Heijer M, Kluijtmans LA, van den Heuvel LP et al (1995) A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 10:111\u2013113","journal-title":"Nat Genet"},{"key":"2507_CR25","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1600-0609.2008.01128.x","volume":"81","author":"PB Kooten Niekerk van","year":"2008","unstructured":"van Kooten Niekerk PB, Schmiegelow K, Schroeder H (2008) Influence of methylene tetrahydrofolate reductase polymorphisms and coadministration of antimetabolites on toxicity after high dose methotrexate. Eur J Haematol 81:391\u2013398","journal-title":"Eur J Haematol"},{"key":"2507_CR26","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1080\/10245330701448479","volume":"12","author":"GJ Ruiz-Arguelles","year":"2007","unstructured":"Ruiz-Arguelles GJ, Coconi-Linares LN, Garces-Eisele J, Reyes-Nunez V (2007) Methotrexate induced mucositis in acute leukemia patients is not associated with the MTHFR 677T allele in Mexico. Hematology 12:387\u2013391","journal-title":"Hematology"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-014-2507-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-014-2507-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-014-2507-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T16:42:37Z","timestamp":1716828157000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-014-2507-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,8]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["2507"],"URL":"https:\/\/doi.org\/10.1007\/s00280-014-2507-8","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,8]]}}}